Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis.

Novel N,N-disubstituted indol-3-ylglyoxylamides (1-56), bearing different combinations of substituents R 1-R 5, were synthesized and evaluated as ligands of the translocator protein (TSPO), the 18 kDa protein representing the minimal functional unit of the "peripheral-type benzodiazepine receptor" (PBR). Most of the new compounds showed a nanomolar/subnanomolar affinity for TSPO and stimulated steroid biosynthesis in rat C6 glioma cells with a potency similar to or higher than that of classic TSPO ligands such as PK 11195. Moreover, when evaluated in vivo by means of the elevated-plus-maze (EPM) paradigm in the rat, compound 32, the best-performing derivative in terms of TSPO affinity and pregnenolone production, showed clear anxiolytic effects. The results of this study suggested that the novel N,N-disubstituted indol-3-ylglyoxylamides may represent a promising class of compounds potentially suited for the treatment of anxiety disorders.

[1]  C. Martini,et al.  P0088 - Platelet 18 kDa translocator protein density is reduced in depressed patients with adult separation anxiety , 2008, European psychiatry.

[2]  F. Da Settimo,et al.  GABA A/Bz receptor subtypes as targets for selective drugs. , 2007, Current medicinal chemistry.

[3]  E. Novellino,et al.  New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation. , 2007, Journal of medicinal chemistry.

[4]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[5]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders , 2006, Neuroscience.

[6]  C. Martini,et al.  Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation. , 2005, Bioorganic & medicinal chemistry.

[7]  C. Martini,et al.  Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms , 2005, Psychopharmacology.

[8]  S. Kurumiya,et al.  Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand , 2004, British journal of pharmacology.

[9]  E. Novellino,et al.  N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor. , 2004, Journal of medicinal chemistry.

[10]  S. Galiègue,et al.  Peripheral benzodiazepine receptors and mitochondrial function , 2002, Neurochemistry International.

[11]  C. Martini,et al.  2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. , 2001, Bioorganic & medicinal chemistry.

[12]  M. Gavish,et al.  Peripheral‐type benzodiazepine receptors: Their implication in brain disease , 2000 .

[13]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[14]  C. Martini,et al.  Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides. , 1999, Journal of medicinal chemistry.

[15]  G. Biggio,et al.  2‐Phenyl‐imidazo[1,2‐a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats , 1999, British journal of pharmacology.

[16]  V. Papadopoulos,et al.  In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  R. Rodgers,et al.  Anxiety, defence and the elevated plus-maze , 1997, Neuroscience & Biobehavioral Reviews.

[18]  E. Novellino,et al.  Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands. , 1996, Journal of medicinal chemistry.

[19]  A. Guidotti,et al.  Benzodiazepines on trial: a research strategy for their rehabilitation. , 1996, Trends in pharmacological sciences.

[20]  G. Dawson,et al.  Use of the elevated plus maze in the search for novel anxiolytic agents. , 1995, Trends in pharmacological sciences.

[21]  A. Guidotti,et al.  Chemistry, binding affinities, and behavioral properties of a new class of "antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. , 1993, Journal of medicinal chemistry.

[22]  V. Papadopoulos.  Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. , 1993, Endocrine reviews.

[23]  A. Guidotti,et al.  2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). , 1992, The Journal of pharmacology and experimental therapeutics.

[24]  G. Primofiore,et al.  N-(Indol-3-ylglyoxylyl)methionine derivatives: preparation and gastric anti-secretory activity , 1988 .

[25]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[26]  J. Bénavidès,et al.  Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. , 1983, Life sciences.

[27]  V. Parrino,et al.  Lithiation of N-(2-alkylphenyl)alkanamides and related compounds. A modified Madelung indole synthesis , 1981 .

[28]  G. Sperk,et al.  Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.